Subscribe To
Here's why catalent (ctlt) is a strong momentum stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...
March 23, 2022, 11:17 am
Catalent's (ctlt) new project completion expands global footprint
Catalent's (CTLT) latest facility transformation is likely to significantly enhance the global Biologics business....
March 21, 2022, 2:18 pm
Reasons to retain catalent (ctlt) stock in your portfolio
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock....
March 9, 2022, 1:32 pm
Catalent's (ctlt) new tie-up to provide better patient access
Catalent's (CTLT) latest collaboration is expected to enable it to provide customers access to the TFF technology....
March 7, 2022, 12:00 pm
Catalent's (ctlt) new tie-up to provide better patient access
Catalent's (CTLT) latest collaboration is expected to enable it to provide customers access to the TFF technology....
March 7, 2022, 12:00 pm
Catalent's (ctlt) new tie-up to provide better patient access
Catalent's (CTLT) latest collaboration is expected to enable it to provide customers access to the TFF technology....
March 7, 2022, 12:00 pm
Catalent, inc. (ctlt) ceo john chiminski on q2 2022 results - earnings call transcript
Catalent, Inc. (CTLT) CEO John Chiminski on Q2 2022 Results - Earnings Call Transcript...
February 2, 2022, 12:09 am
Catalent, inc. (ctlt) ceo john chiminski on q2 2022 results - earnings call transcript
Catalent, Inc. (CTLT) CEO John Chiminski on Q2 2022 Results - Earnings Call Transcript...
February 2, 2022, 12:09 am
Catalent, inc. (ctlt) ceo john chiminski on q2 2022 results - earnings call transcript
Catalent, Inc. (CTLT) CEO John Chiminski on Q2 2022 Results - Earnings Call Transcript...
February 2, 2022, 12:09 am
Catalent (ctlt) surpasses q2 earnings and revenue estimates
Catalent (CTLT) delivered earnings and revenue surprises of 7.14% and 5.05%, respectively, for the quarter ended December 2021. Do the numbers hold cl...
February 1, 2022, 9:59 am
Catalent (ctlt) surpasses q2 earnings and revenue estimates
Catalent (CTLT) delivered earnings and revenue surprises of 7.14% and 5.05%, respectively, for the quarter ended December 2021. Do the numbers hold cl...
February 1, 2022, 9:59 am
Catalent (ctlt) surpasses q2 earnings and revenue estimates
Catalent (CTLT) delivered earnings and revenue surprises of 7.14% and 5.05%, respectively, for the quarter ended December 2021. Do the numbers hold cl...
February 1, 2022, 9:59 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Catalent's q2 earnings beat street view, lifts fy22 guidance
Catalent Inc CTLT has reported Q2 FY22 sales of $1.22 billion, +34% Y/Y as reported, or 35% in constant currency, edging out analysts' average expec...
February 1, 2022, 8:14 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am